ClinicalTrials.gg
CompletedNCT01679015Updated Jun 3, 2016

Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes

An observational study in Dry Eyes and Allergic Conjunctivitis, sponsored by Schwartz Laser Eye Center. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-06-03.

Sponsored by Schwartz Laser Eye Center · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
250
Ages
18 Years and older
Sex
All
01

Study summary

Evaluating the percentage of patients that suffer from eye allergies and determining whether they also have dry eyes.

02

Conditions studied

  • Dry Eyes
  • Allergic Conjunctivitis

Keywords

  • Burning
  • Dryness
  • Itching
  • Blurry Vision
03

In context

Dry Eye Syndromes

1,325 studies on the registry are indexed under Dry Eye Syndromes; 193 are open to participants now.

This study's enrollment of 250 is above the median of 89 across 176 observational studies indexed under Dry Eye Syndromes.

Browse Dry Eye Syndromes studies →

Lead sponsor

This is the only study on the registry with Schwartz Laser Eye Center as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients will be screened from existing patient database.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ability to give informed consent
  • Males and females at least 18 years of age
  • Personal history of allergic disorders including but not limited to allergic conjunctivitis, allergic rhinitis, contact dermatitis and other eczema, and asthma
  • Diagnosis of allergic conjunctivitis
  • Presence of any of the following signs including conjunctival redness and papillae, chemosis, red edematous eyelids, reduced tear clearance, reduced TBUT, vital staining, stringy discharge, and/or symptoms including ocular itching, burning and tearing, runny nose or itchy throat

Exclusion criteria

Exclusion Criteria:

  • Active ocular or systemic infection
  • History of ocular infection within past 6 months
  • Presence of punctal plugs
  • Recent ocular surgery within past 6 months
  • Current use of chemotherapeutic agents
  • Presence of ocular trauma
  • Inability to give informed consent
  • Women who are pregnant, nursing or lactating
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
250 participants (actual)

Groups and cohorts

  • Dry Eyes, Eye Allergies

    Patients with ocular allergies and those with dry eyes.

06

What researchers measure

Primary outcomes

  1. Prevalence of dry eye in an allergic population presenting to a high volume optometry practice

    Time frame: up to 2 years

Secondary outcomes

  1. Prevalence of allergic patients with moderate to severe ocular signs and symptoms

    Time frame: up to 2 years

07

Study locations

1 site
  • Schwartz Laser Eye Center
    Scottsdale, Arizona 85260, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01679015
Lead sponsor
Schwartz Laser Eye Center
Collaborators
Allergan
Responsible party
Marc R.Bloomenstein (O.D., Schwartz Laser Eye Center) — Principal investigator
First posted
Sep 5, 2012
Start date
Aug 2012
Primary completion
Feb 2014
Completion
Feb 2014
Last update
Jun 3, 2016

Study contacts

Marc R Bloomenstein, O.D.
principal investigator · Schwartz Laser Eye Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion